UP

US approves new drug to treat Alzheimer's disease

Home page Science
12 Punto 14 Punto 16 Punto 18 Punto
US approves new drug to treat Alzheimer's disease

The US Food and Drug Administration on Friday approved a highly anticipated new drug designed to slow cognitive decline in patients in mild and early stages of Alzheimer's disease.

Axar.az reports the FDA approval of the drug, Leqembi, also known as lecanemab, comes just days after the regulatory agency was harshly criticised in a congressional report for its green-lighting of another Alzheimer's drug, Aduhelm.

And it was granted despite trial results showing the monoclonal antibody treatment carries risks of brain swelling and bleeding.

Both drugs were approved through an accelerated process that allows the FDA to fast-track approval of drugs for serious conditions where there is an unmet medical need.

Date
2023.01.07 / 11:38
Author
Axar.az
See also

Azerbaijan marks National Revival Day today

President Aliyev commemorates National Revival Day

Iran says it has shot down MQ-1 drone over Hormuz

Azerbaijan beat Andorra 3-1 in friendly

Russian strike on Komyshuvakha kills 72, four missing

Iran activates air defense systems in Isfahan

Estonia summons Russian diplomat over Threod Systems attack

Hajiyev meets EU envoy for South Caucasus

China confirms first-ever trilateral meeting of three leaders

Leyla Aliyeva attends opening of Garachukhur Sports Hall

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla